Improving the Effectiveness of Treatment for Depression in Hispanics

NCT00742573 Phase 2 COMPLETED Results posted

This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.

Details

Lead sponsor	New York State Psychiatric Institute
Phase	Phase 2
Status	COMPLETED
Enrolment	170
Start date	2008-08
Completion	2014-01-10

Conditions

• Major Depressive Disorder

Interventions

• Antidepressants through Texas Medication Algorithm (TMA)
• Brief Interpersonal Psychotherapy (IPT-B)

Primary outcomes

• Mean Time of Retention — 52 weeks
  Average number of weeks of retention of Hispanics in the treatment of MDD
• Hamilton Depression Scale (HAMD-17) — Baseline
  Hamilton Depression Scale (HAMD-17): Scoring is based on the 17-item scale of 0-4, the higher the worse. 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression, over 24 severe depression Minimum is 0 and the maximum score being 52

Countries

United States